Neoadjuvant Nsclc
Research payments
$6,521,653
Through program year 2025, $6,521,653 in research payments was reported against Neoadjuvant Nsclc, across 1,183 payments, paid by Genentech, Inc..
- Paid by
- Genentech, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $418,594 | 103 |
| 2024 | Research | $385,384 | 130 |
| 2023 | Research | $854,791 | 142 |
| 2022 | Research | $564,432 | 172 |
| 2021 | Research | $1,331,115 | 229 |
| 2020 | Research | $1,338,755 | 218 |
| 2019 | Research | $1,628,581 | 189 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Nagashree Seetharamu New Hyde Park, NY Named on 63 payments
- Jorge Nieva Los Angeles, CA Named on 37 payments
- Arielle Lee Tyler, TX Named on 34 payments
- Timothy Byun Orange, CA Named on 33 payments
- Aaron Mansfield Rochester, MN Named on 33 payments
- David Spigel Nashville, TN Named on 27 payments
- Brian Patson Allentown, PA Named on 25 payments
- Greg Gerstner Peoria, IL Named on 23 payments
- Naiyer Rizvi New York, NY Named on 20 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.